Indian stock exchange

VIQ Solutions Closes Oversubscribed Private Placement Financing

Retrieved on: 
Tuesday, February 27, 2024

VIQ Solutions Inc. (“VIQ”, “VIQ Solutions” or the “Company”) (TSX: VQS) today announces that it has closed a non-brokered private placement of 10,239,000 common shares of the Company (collectively, the “Common Shares”) at a price per Common Share of C$0.158 for aggregate gross proceeds of C$1,617,762.00 (the “Offering”).

Key Points: 
  • VIQ Solutions Inc. (“VIQ”, “VIQ Solutions” or the “Company”) (TSX: VQS) today announces that it has closed a non-brokered private placement of 10,239,000 common shares of the Company (collectively, the “Common Shares”) at a price per Common Share of C$0.158 for aggregate gross proceeds of C$1,617,762.00 (the “Offering”).
  • VIQ intends to use the net proceeds from the Offering for working capital and general corporate purposes.
  • The Common Shares will be subject to a statutory hold period or restricted period in Canada of four months and one day following the closing date.
  • The purchasers of the Common Shares and the extent of such participation were not finalized until shortly prior to the completion of the Offering.

Electra Provides Corporate Update

Retrieved on: 
Tuesday, February 27, 2024

In the event of a default by the Company under the Indenture, the Company is required to pay the Interest immediately.

Key Points: 
  • In the event of a default by the Company under the Indenture, the Company is required to pay the Interest immediately.
  • The Company has agreed to satisfy US$400,732 of the Interest through the issuance of Common Shares to certain Noteholders (the “Share Issuance”).
  • Such forward-looking statements include, without limitation, statements regarding completion of the Share Issuance and the postponement of the Interest.
  • Except where required by applicable law, the Company disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

XP Inc Announces New Share Repurchase Program

Retrieved on: 
Tuesday, February 27, 2024

XP Inc. (Nasdaq: XP), announced today that its board of directors has approved a new share repurchase program, which aims to neutralize future shareholder dilution due to the vesting of Restricted Stock Units (RSUs) from the Company’s long-term incentive plan.

Key Points: 
  • XP Inc. (Nasdaq: XP), announced today that its board of directors has approved a new share repurchase program, which aims to neutralize future shareholder dilution due to the vesting of Restricted Stock Units (RSUs) from the Company’s long-term incentive plan.
  • Under the approved repurchase program for 2024, XP may repurchase up to 2,500,000 Class A Common Shares within the period commencing on February 28, 2024, and ending on December 27, 2024.
  • XP’s board of directors will review the repurchase program periodically and may authorize adjustments to its terms and size or suspend or discontinue the repurchase program.
  • XP expects to utilize its existing cash to fund repurchases made under the repurchase program.

XTM Announces Completion of Oversubscribed Non-Brokered Secured Convertible Debenture Offering for US $11Million

Retrieved on: 
Saturday, February 24, 2024

The secured convertible debentures will bear interest at the rate of 12.0% per annum from the date of issuance, calculated and payable quarterly beginning on September 30, 2024.

Key Points: 
  • The secured convertible debentures will bear interest at the rate of 12.0% per annum from the date of issuance, calculated and payable quarterly beginning on September 30, 2024.
  • “We are poised and ready to take on the reported 75% of US workers who want same day pay,” said Marilyn Schaffer, XTM, CEO.
  • In connection with the Offering, XTM paid a further cash finder’s fee in the amount of US400,000 to a finder (the “Finder”).
  • The securities issued in connection with the Offering are subject to a statutory hold period of four months and one day from the date of issuance.

PESG Industry Updates: Germany's Cannabis Act and Its Impact on the Medical Cannabis Landscape

Retrieved on: 
Friday, February 23, 2024

Germany is expected to pass the Cannabis Act today (Friday), heralding a transformative era for the medical cannabis industry.

Key Points: 
  • Germany is expected to pass the Cannabis Act today (Friday), heralding a transformative era for the medical cannabis industry.
  • The passage of the Cannabis Act represents a pivotal shift, primarily by making it substantially easier and more cost-effective for doctors to prescribe medical cannabis.
  • The Act's facilitation of the prescription process is anticipated to lead to a surge in demand for medical cannabis.
  • Looking ahead, Germany's Cannabis Act marks a significant milestone for the medical cannabis industry, promising to increase demand, expand the patient base, and reduce prices through heightened competition.

American States Water Company Announces Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Wednesday, February 21, 2024

On June 29, 2023, the CPUC adopted a final decision in GSWC's general rate case application that determines new water rates for the years 2022–2024 retroactive to January 1, 2022.

Key Points: 
  • On June 29, 2023, the CPUC adopted a final decision in GSWC's general rate case application that determines new water rates for the years 2022–2024 retroactive to January 1, 2022.
  • GSWC filed for the implementation of new 2023 rate increases that became effective on July 31, 2023.
  • In October 2023, GSWC also filed with the CPUC to recover all retroactive rate amounts accumulated in memorandum accounts for the full 2022 year and for 2023 through July 30, 2023.
  • For more details on the full year 2023 results, please refer to the company’s Form 10-K filed with the Securities and Exchange Commission.

Eve Holding, Inc. Reports Fourth Quarter and FY2023 Results

Retrieved on: 
Friday, March 8, 2024

MELBOURNE, Fla., March 8, 2024 /PRNewswire/ -- Eve Holding, Inc. ("Eve") (NYSE: EVEX and EVEXW) reports its fourth quarter and fiscal year 2023 earnings results.

Key Points: 
  • MELBOURNE, Fla., March 8, 2024 /PRNewswire/ -- Eve Holding, Inc. ("Eve") (NYSE: EVEX and EVEXW) reports its fourth quarter and fiscal year 2023 earnings results.
  • Eve Air Mobility accomplished several milestones on our journey to shape the global Urban Air Mobility (UAM) ecosystem in 2023.
  • Our R&D costs are primarily driven by the MSA with Embraer that performs several developmental activities for Eve.
  • R&D associated with Eve's aircraft development and SG&A expenses were the main contributors to the higher cash consumption during the quarter.

Smart Packaging Innovation Pushes Ophthalmic Market to $527.8 Million by 2034

Retrieved on: 
Thursday, March 7, 2024

Ophthalmic Drug Packaging Market Overview:

Key Points: 
  • Ophthalmic Drug Packaging Market Overview:
    The global ophthalmic drug packaging market is expected to grow steadily, reaching an estimated value of US$527.8 million by 2034, according to Future Market Insights' recent study.
  • One of the challenges in the global ophthalmic drug packaging market is assuring compatibility between novel packaging materials and sensitive ophthalmic medicines.
  • The global ophthalmic drug packaging market size reached US$ 222.3 million in 2019.
  • Future Market Insights offers an unbiased analysis of the ophthalmic drug packaging market, providing historical data for 2019 to 2022 and forecast statistics from 2023 to 2033.

Smart Packaging Innovation Pushes Ophthalmic Market to $527.8 Million by 2034

Retrieved on: 
Thursday, March 7, 2024

Ophthalmic Drug Packaging Market Overview:

Key Points: 
  • Ophthalmic Drug Packaging Market Overview:
    The global ophthalmic drug packaging market is expected to grow steadily, reaching an estimated value of US$527.8 million by 2034, according to Future Market Insights' recent study.
  • One of the challenges in the global ophthalmic drug packaging market is assuring compatibility between novel packaging materials and sensitive ophthalmic medicines.
  • The global ophthalmic drug packaging market size reached US$ 222.3 million in 2019.
  • Future Market Insights offers an unbiased analysis of the ophthalmic drug packaging market, providing historical data for 2019 to 2022 and forecast statistics from 2023 to 2033.

NANALYSIS ANNOUNCES UP TO $5.0 MILLION BEST EFFORTS PROSPECTUS EXEMPT OFFERING PURSUANT TO THE LISTED ISSUER EXEMPTION AND UP TO $1.0 MILLION CONCURRENT PRIVATE PLACEMENT

Retrieved on: 
Wednesday, March 6, 2024

There is an offering document relating to the Offering that can be accessed under the Company's profile at www.sedarplus.ca and at www.nanalysis.com .

Key Points: 
  • There is an offering document relating to the Offering that can be accessed under the Company's profile at www.sedarplus.ca and at www.nanalysis.com .
  • Prospective investors should read this offering document before making an investment decision.
  • The Company will also be simultaneously conducting a concurrent brokered "best efforts" prospectus exempt offering of Units of the Company, on the same terms as the Offering, for gross proceeds of up to approximately $1,000,000 by way of a private placement.
  • Certain insiders of the Company may participate in the Concurrent Offering.